Mohammad Hussain, MD

Mohammad Hussain, MD

Hematologist/Oncologist
Cancer Care
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment
Languages:
English, English

    About me

    Gender

    Male

    Additional languages spoken

    English

    Education & training

    Positions
    Assistant Professor
    Board Certifications
    Internal Medicine
    Medical Oncology
    Hematology
    Medical School
    Allama Iqbal Medical College University of Punjab, Pakistan
    Residency
    Pinnacle Health Hospitals, Harrisburg, PA (UPMC)
    Fellowship
    Hematology and Oncology, Levine Cancer Institute, Charlotte, NC and Blood and Marrow Transplant, Stanford University School of Medicine

    Specialties

    Conditions

    Patients in waiting room

    Appointments

    SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community. 

    Clinical locations

    Locations

    SIU Medicine Cancer Care | Springfield

    315 W. Carpenter St. Springfield, IL 62702 1st Floor, Clinic B
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm

    Hospital privileges

    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL

    Featured Publications

    [1] Rios J.  Alnoud M.  Hussain MS.  Ayas Z.  Franco E.  Mills J.  Nwose J.  Malbas MS.  Garcia H.  Tripathi MK.  Benamar K.  Neuropathic Pain and Related Depression in Mice: The Effect of a Terpene and a Minor Cannabinoid in Combination.  2025 Dec;13(12):. 
    PMID: 41463111

    [2] Hussain MZ.  Naik VY.  Goswami K.  Jana A.  Microwave-Promoted One-Pot Sustainable Synthesis of Fluorogenic Amino Acids: Late-Stage Diversification of Peptides.  2026 Jan;91(1):227-237. 
    PMID: 41428334

    [3] Pe T.  Inthavong P.  Beavon E.  Muleme M.  Bohora S.  Roder C.  Clarke NE.  Richmond JA.  Hussain MA.  Titulaer A.  Doyle J.  Tai A.  Athan E.  Wilson A.  Wade AJ.  Viral hepatitis notifications: a cohort study of enhanced local follow-up in Victoria.  2025 Dec;():. 
    PMID: 41412589

    Read All Publications

    Clinical trials

    Trial
    Simmons Cancer Institute

    KO-MEN-008: Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia

    Active recruiting

    Examining the safety, tolerability, and effectiveness of investigational drug ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia. The study drug will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.

    Contact: Kathy Robinson 217-545-1946
    Trial
    Simmons Cancer Institute

    A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417as Monotherapy, in Combination With Dexamethasone and Carfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)

    Active recruiting
    The purpose of the study is to test BGB-11417 (alone, with dexamethasone, and with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma who test positive for t(11;14).
    Contact: Kathy Robinson 217-545-1946